Fichtner-Feigl S - Search Results

1

KMT9 Controls Stemness and Growth of Colorectal Cancer.

Berlin C, Cottard F, Willmann D, Urban S, Tirier SM, Marx L, Rippe K, Schmitt M, Petrocelli V, Greten FR, Fichtner-Feigl S, Kesselring R, Metzger E, Schüle R. Berlin C, et al. Cancer Res. 2022 Jan 15;82(2):210-220. doi: 10.1158/0008-5472.CAN-21-1261. Epub 2021 Nov 4. Cancer Res. 2022. PMID: 34737213

2

Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice.

Jauch D, Martin M, Schiechl G, Kesselring R, Schlitt HJ, Geissler EK, Fichtner-Feigl S. Jauch D, et al. Gut. 2011 Dec;60(12):1678-86. doi: 10.1136/gutjnl-2011-300612. Epub 2011 Sep 23. Gut. 2011. PMID: 21948944

3

Immune responses triggering colitis and colitis-associated carcinoma.

Kesselring R, Fichtner-Feigl S. Kesselring R, et al. Langenbecks Arch Surg. 2012 Apr;397(4):527-33. doi: 10.1007/s00423-012-0927-7. Epub 2012 Mar 1. Langenbecks Arch Surg. 2012. PMID: 22382701 Review.

4

Interleukin 21 impairs tumor immunosurveillance of colitis-associated colorectal cancer.

Kesselring R, Jauch D, Fichtner-Feigl S. Kesselring R, et al. Oncoimmunology. 2012 Jul 1;1(4):537-538. doi: 10.4161/onci.19407. Oncoimmunology. 2012. PMID: 22754778 Free PMC article.

5

Inhibition of innate co-receptor TREM-1 signaling reduces CD4(+) T cell activation and prolongs cardiac allograft survival.

Schiechl G, Brunner SM, Kesselring R, Martin M, Ruemmele P, Mack M, Hirt SW, Schlitt HJ, Geissler EK, Fichtner-Feigl S. Schiechl G, et al. Am J Transplant. 2013 May;13(5):1168-80. doi: 10.1111/ajt.12186. Epub 2013 Mar 6. Am J Transplant. 2013. PMID: 23463907 Free article.

6

IL-13 signaling via IL-13Rα2 triggers TGF-β1-dependent allograft fibrosis.

Brunner SM, Schiechl G, Kesselring R, Martin M, Balam S, Schlitt HJ, Geissler EK, Fichtner-Feigl S. Brunner SM, et al. Transplant Res. 2013 Oct 22;2(1):16. doi: 10.1186/2047-1440-2-16. Transplant Res. 2013. PMID: 24143891 Free PMC article.

7

IL-13 orchestrates resolution of chronic intestinal inflammation via phosphorylation of glycogen synthase kinase-3β.

Fichtner-Feigl S, Kesselring R, Martin M, Obermeier F, Ruemmele P, Kitani A, Brunner SM, Haimerl M, Geissler EK, Strober W, Schlitt HJ. Fichtner-Feigl S, et al. J Immunol. 2014 Apr 15;192(8):3969-80. doi: 10.4049/jimmunol.1301072. Epub 2014 Mar 14. J Immunol. 2014. PMID: 24634488

8

The complement receptors CD46, CD55 and CD59 are regulated by the tumour microenvironment of head and neck cancer to facilitate escape of complement attack.

Kesselring R, Thiel A, Pries R, Fichtner-Feigl S, Brunner S, Seidel P, Bruchhage KL, Wollenberg B. Kesselring R, et al. Eur J Cancer. 2014 Aug;50(12):2152-61. doi: 10.1016/j.ejca.2014.05.005. Epub 2014 Jun 7. Eur J Cancer. 2014. PMID: 24915776

9

RORγt(+) hematopoietic cells are necessary for tumor cell proliferation during colitis-associated tumorigenesis in mice.

Martin M, Kesselring RK, Saidou B, Brunner SM, Schiechl G, Mouris VF, Wege AK, Rümmele P, Schlitt HJ, Geissler EK, Fichtner-Feigl S. Martin M, et al. Eur J Immunol. 2015 Jun;45(6):1667-79. doi: 10.1002/eji.201444915. Epub 2015 May 15. Eur J Immunol. 2015. PMID: 25820779 Free article.

10

Chronic inflammation and the development of malignancy in the GI tract.

Fichtner-Feigl S, Kesselring R, Strober W. Fichtner-Feigl S, et al. Trends Immunol. 2015 Aug;36(8):451-9. doi: 10.1016/j.it.2015.06.007. Epub 2015 Jul 18. Trends Immunol. 2015. PMID: 26194796 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page